Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D D Schoepp

Showing results (71-80 of 130) with videos related to

Pageof 13
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1994
Contractile serotonin-2A receptor signal transduction in guinea pig trachea: importance of protein kinase C and extracellular and intracellular calcium but not phosphoinositide hydrolysisS W Watts, D A Cox, B G Johnson, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 22, 1999
Physiological antagonism between 5-hydroxytryptamine(2A) and group II metabotropic glutamate receptors in prefrontal cortexG J Marek, R A Wright, D D Schoepp, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 7, 1998
Anxiolytic and side-effect profile of LY354740: a potent, highly selective, orally active agonist for group II metabotropic glutamate receptorsD R Helton, J P Tizzano, J A Monn, et al.
Neuropharmacology|March 28, 1998
LY354740: a metabotropic glutamate receptor agonist which ameliorates symptoms of nicotine withdrawal in ratsD R Helton, J P Tizzano, J A Monn, et al.
Journal of Neurochemistry|May 1, 1991
In vitro and in vivo pharmacology of trans- and cis-(+-)-1-amino-1,3-cyclopentanedicarboxylic acid: dissociation of metabotropic and ionotropic excitatory amino acid receptor effectsD D Schoepp, B G Johnson, C R Salhoff, et al.
Brain Research|August 2, 2005
Thyrotropin-releasing hormone (protirelin) inhibits potassium-stimulated glutamate and aspartate release from hippocampal slices in vitroY Nie, D D Schoepp, J E Klaunig, et al.
Neuroscience Letters|October 21, 1998
Effects of the selective metabotropic glutamate agonist LY354740 in a rat model of permanent ischaemiaA G Lam, M A Soriano, J A Monn, et al.
European Journal of Pharmacology|August 24, 1999
Neuroprotection by metabotropic glutamate receptor glutamate receptor agonists: LY354740, LY379268 and LY389795A E Kingston, M J O'Neill, A Lam, et al.
Journal of Neurochemistry|March 1, 1994
Disruption of potential alpha-helix in the G loop of the guinea pig 5-hydroxytryptamine2 receptor does not prevent receptor coupling to phosphoinositide hydrolysisS W Watts, M L Cohen, P Q Mooney, et al.
Journal of Medicinal Chemistry|July 22, 1994
Discovery of a potent, peripherally selective trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine opioid antagonist for the treatment of gastrointestinal motility disordersD M Zimmerman, J S Gidda, B E Cantrell, et al.
Pageof 13

Showing results (71-80 of 130) with videos related to

Sort By:
Pageof 13
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1994
Contractile serotonin-2A receptor signal transduction in guinea pig trachea: importance of protein kinase C and extracellular and intracellular calcium but not phosphoinositide hydrolysisS W Watts, D A Cox, B G Johnson, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 22, 1999
Physiological antagonism between 5-hydroxytryptamine(2A) and group II metabotropic glutamate receptors in prefrontal cortexG J Marek, R A Wright, D D Schoepp, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 7, 1998
Anxiolytic and side-effect profile of LY354740: a potent, highly selective, orally active agonist for group II metabotropic glutamate receptorsD R Helton, J P Tizzano, J A Monn, et al.
Neuropharmacology|March 28, 1998
LY354740: a metabotropic glutamate receptor agonist which ameliorates symptoms of nicotine withdrawal in ratsD R Helton, J P Tizzano, J A Monn, et al.
Journal of Neurochemistry|May 1, 1991
In vitro and in vivo pharmacology of trans- and cis-(+-)-1-amino-1,3-cyclopentanedicarboxylic acid: dissociation of metabotropic and ionotropic excitatory amino acid receptor effectsD D Schoepp, B G Johnson, C R Salhoff, et al.
Brain Research|August 2, 2005
Thyrotropin-releasing hormone (protirelin) inhibits potassium-stimulated glutamate and aspartate release from hippocampal slices in vitroY Nie, D D Schoepp, J E Klaunig, et al.
Neuroscience Letters|October 21, 1998
Effects of the selective metabotropic glutamate agonist LY354740 in a rat model of permanent ischaemiaA G Lam, M A Soriano, J A Monn, et al.
European Journal of Pharmacology|August 24, 1999
Neuroprotection by metabotropic glutamate receptor glutamate receptor agonists: LY354740, LY379268 and LY389795A E Kingston, M J O'Neill, A Lam, et al.
Journal of Neurochemistry|March 1, 1994
Disruption of potential alpha-helix in the G loop of the guinea pig 5-hydroxytryptamine2 receptor does not prevent receptor coupling to phosphoinositide hydrolysisS W Watts, M L Cohen, P Q Mooney, et al.
Journal of Medicinal Chemistry|July 22, 1994
Discovery of a potent, peripherally selective trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine opioid antagonist for the treatment of gastrointestinal motility disordersD M Zimmerman, J S Gidda, B E Cantrell, et al.
Pageof 13